SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-118169
Filing Date
2023-11-14
Accepted
2023-11-14 16:30:30
Documents
3
Period of Report
2023-12-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2329604-2_def14a.htm DEF 14A 220841
2 GRAPHIC px_23page01-bw.jpg GRAPHIC 215415
3 GRAPHIC px_23page02-bw.jpg GRAPHIC 199903
  Complete submission text file 0001104659-23-118169.txt   761873
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 231406965
SIC: 2834 Pharmaceutical Preparations